Approval for the addition of the assay to the modular analytics e170 (elecsys module) immunoassay analyzer. The device, as modified, will be marketed under the trade name elecsys total psa immunoassay and elecsys total psa calset and are indicated as follows: the elecsys total psa immunoassay, a quantitative in vitro diagnostic test for total prostate-specific antigen (tpsa) in human serum and plasma, is indicated for the measurement of total psa in conjunction with digital rectal examination (dre) as an aid in the detection of prostate cancer in men aged 50 years or older. Prostate biopsy is required for diagnosis of prostate cancer. The test is further indicated for serial measurement of tpsa to aid in the management of cancer patients. The electrochemilumin-escence immunoassay "eclia" is intended for use on the roche elecsys 1010/2010 and modular analytics e170 (elecsys module) immunoassay analyzers.
Device | ELECSYS TOTAL PSA IMMUNOASSAY/TOTAL PSA CALSET |
Classification Name | Prostate-specific Antigen (psa) For Management Of Prostate Cancers |
Generic Name | Prostate-specific Antigen (psa) For Management Of Prostate Cancers |
Applicant | ROCHE DIAGNOSTICS CORP. |
Date Received | 2001-10-09 |
Decision Date | 2002-02-08 |
PMA | P990056 |
Supplement | S001 |
Product Code | LTJ |
Advisory Committee | Immunology |
Supplement Type | Normal 180 Day Track |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | ROCHE DIAGNOSTICS CORP. 9115 Hague Rd. indianapolis, IN 46250 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P990056 | | Original Filing |
S038 |
2021-10-18 |
30-day Notice |
S037 |
2019-11-14 |
Normal 180 Day Track |
S036 |
2019-01-29 |
Real-time Process |
S035 |
2018-10-26 |
Normal 180 Day Track No User Fee |
S034 |
2018-10-01 |
30-day Notice |
S033 |
2018-04-17 |
Real-time Process |
S032 |
2018-04-03 |
30-day Notice |
S031 |
2018-03-01 |
Real-time Process |
S030 | | |
S029 |
2017-10-11 |
Real-time Process |
S028 |
2017-07-31 |
Normal 180 Day Track |
S027 |
2017-08-03 |
30-day Notice |
S026 |
2017-05-24 |
30-day Notice |
S025 |
2016-10-26 |
30-day Notice |
S024 |
2016-09-07 |
Normal 180 Day Track No User Fee |
S023 |
2016-02-18 |
30-day Notice |
S022 |
2015-10-07 |
30-day Notice |
S021 |
2014-04-04 |
Real-time Process |
S020 |
2013-04-09 |
Real-time Process |
S019 |
2012-11-30 |
30-day Notice |
S018 | | |
S017 |
2012-02-29 |
30-day Notice |
S016 |
2012-01-31 |
135 Review Track For 30-day Notice |
S015 |
2011-11-22 |
30-day Notice |
S014 |
2011-08-01 |
Normal 180 Day Track |
S013 |
2011-05-03 |
Normal 180 Day Track No User Fee |
S012 |
2011-04-25 |
30-day Notice |
S011 |
2011-04-11 |
135 Review Track For 30-day Notice |
S010 |
2009-10-07 |
135 Review Track For 30-day Notice |
S009 |
2008-09-02 |
30-day Notice |
S008 |
2008-03-28 |
Normal 180 Day Track |
S007 |
2007-08-22 |
Normal 180 Day Track |
S006 |
2006-12-28 |
30-day Notice |
S005 | | |
S004 |
2006-10-05 |
Real-time Process |
S003 |
2006-02-13 |
Normal 180 Day Track |
S002 |
2006-01-23 |
Special (immediate Track) |
S001 |
2001-10-09 |
Normal 180 Day Track |
NIH GUDID Devices